News

Jan 30

0

Medullary Thyroid Carcinoma (MTC) Registry Consortium Partnering with ATA to create Registry

By lightoflife | | No Comments

Mar 31

0

Philadelphia Couple Raises Money for Thyroid Cancer Research

By Carlos Ramos | | No Comments

Mar 31

1

U.S. Prescribing Information for Thyrogen Revised to Include Use of Wider Range of Radioiodine in Patients

By Carlos Ramos | | No Comments

Mar 31

2

FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism

By Carlos Ramos | | No Comments

Mar 31

0

Eiasi is pleased to announce that LENVIMATM (lenvatinib) is now approved for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC).

By Carlos Ramos | | No Comments

Mar 27

2

New Myths and Truths About Thyroid Cancer Education Initiative Aims to Shine a Light on the Truths about Thyroid

By Carlos Ramos | | No Comments

Mar 22

0

Genzyme Announces Financial Assistance for Thyrogen®

By Carlos Ramos | | No Comments